Miami-based TissueTech, a product developer for ophthalmology, optometry, musculoskeletal and wound care, completed a $10 million round of growth equity financing, according to a Miami Herald Business report.
Ballast Point Ventures and River Cities Capital Funds participated. The funding will help TissueTech develop commercial efforts and further research for all divisions.
More Articles on Ophthalmology:
Dr. Derek Ohlstein Joins St. Lucie Eye Associates in Florida
Silver Oak Service Partners Sells Ownership Stake in Physicians Endoscopy
Dr. Brian Jenkins Joins Hamilton Eye Institute at the University of Tennessee